TenaRx Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
TenaRx General Information
Description
Developer of selective CLK/DYRK kinase inhibitors designed to reprogram cellular fate and master-regulate immune, metabolic, and neurodevelopmental pathways. The company is currently operating in Stealth Mode.
Contact Information
Website
www.tenarx.comOwnership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- 6555 Nancy Ridge Drive
- Suite 300
- San Diego, CA 92121
- United States
Primary Industry
Decision/Risk Analysis
Other Industries
Drug Discovery
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
- 6555 Nancy Ridge Drive
- Suite 300
- San Diego, CA 92121
- United States
TenaRx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Mar-2026 | Completed | Stealth |
TenaRx Patents
TenaRx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250206746-A1 | 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof | Pending | 22-Dec-2023 | ||
| US-12661352-B2 | Combination therapy with clk/dyrk inhibitors and bcl2 inhibitors to treat leukemia | Active | 12-Oct-2023 | ||
| US-20250375442-A1 | Combination therapy with clk/dyrk inhibitors and bcl2 inhibitors to treat leukemia | Active | 12-Oct-2023 | ||
| US-12729205-B2 | 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof | Active | 23-Jun-2022 | ||
| US-20240002391-A1 | 4-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof | Active | 23-Jun-2022 | C07D487/04 |
TenaRx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Polar Light Ventures | Venture Capital | Minority |
TenaRx FAQs
-
When was TenaRx founded?
TenaRx was founded in 2025.
-
Where is TenaRx headquartered?
TenaRx is headquartered in San Diego, CA.
-
What industry is TenaRx in?
TenaRx’s primary industry is Decision/Risk Analysis.
-
Is TenaRx a private or public company?
TenaRx is a Private company.
-
What is TenaRx’s current revenue?
The current revenue for TenaRx is .
-
Who are TenaRx’s investors?
Polar Light Ventures has invested in TenaRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process